Novartis Pharma AG

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Novartis Pharma AG
CIK #0001030617
EDGAR Form CIK 2011 - 2025
3 [0001030617]
4 [0001030617]
SC 13D [0001030617]
SC 13G [0001030617]
Form 13D/13G Filer Form 13D/13G Subject Filed
Novartis Pharma AG Erasca Inc [2022-12-19]
Novartis Pharma AG Precision Biosciences Inc [2022-06-27]
Novartis Pharma AG Somalogic Inc [2021-10-08]
Novartis Pharma AG Poseida Therapeutics Inc [2021-02-12]
Novartis Pharma AG Cellular Biomedicine Group Inc [2020-08-14]
Novartis Pharma AG Gamida Cell Ltd [2018-11-08]
Novartis Pharma AG Cellular Biomedicine Group Inc [2018-09-28]
Novartis Pharma AG Akcea Therapeutics Inc [2017-07-27]
Novartis Pharma AG BioLineRx Ltd [2014-12-22]
Form 3/4/5 Subject 2011 - 2025
Novartis Pharma AG
Precision Biosciences Inc
Novartis AG
Cellular Biomedicine Group, Inc.
Poseida Therapeutics, Inc.
Idenix Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Terms | Privacy | Guide
tony@aum13f.com